vs
Side-by-side financial comparison of Pintec Technology Holdings Ltd (JF) and PureTech Health plc (PRTC). Click either name above to swap in a different company.
Pintec Technology Holdings Ltd is the larger business by last-quarter revenue ($295.2K vs $180.0K, roughly 1.6× PureTech Health plc). Pintec Technology Holdings Ltd runs the higher net margin — -31.0% vs -22820.6%, a 22789.5% gap on every dollar of revenue.
Pintec Technology Holdings Ltd is a fintech SaaS provider offering end-to-end digital financial solutions. Its core services include intelligent risk management, digital lending facilitation, and wealth management tools, serving banks, consumer finance firms and e-commerce platforms primarily in the Chinese market.
PureTech Health plcPRTCEarnings & Financial Report
PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange.
JF vs PRTC — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2023
| Metric | | |
|---|---|---|
| Revenue | $295.2K | $180.0K |
| Net Profit | $-91.6K | $-41.1M |
| Gross Margin | 60.9% | — |
| Operating Margin | -47.2% | -38908.9% |
| Net Margin | -31.0% | -22820.6% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.00 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | $295.2K | — | ||
| Q2 24 | $289.0K | — | ||
| Q4 23 | — | $180.0K |
| Q2 25 | $-91.6K | — | ||
| Q2 24 | $-161.6K | — | ||
| Q4 23 | — | $-41.1M |
| Q2 25 | 60.9% | — | ||
| Q2 24 | 59.6% | — | ||
| Q4 23 | — | — |
| Q2 25 | -47.2% | — | ||
| Q2 24 | -51.1% | — | ||
| Q4 23 | — | -38908.9% |
| Q2 25 | -31.0% | — | ||
| Q2 24 | -55.9% | — | ||
| Q4 23 | — | -22820.6% |
| Q2 25 | $0.00 | — | ||
| Q2 24 | $0.00 | — | ||
| Q4 23 | — | $-0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $653.0K | $191.1M |
| Total DebtLower is stronger | — | $0 |
| Stockholders' EquityBook value | — | $458.2M |
| Total Assets | $1.9M | $694.0M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | $653.0K | — | ||
| Q2 24 | $863.7K | — | ||
| Q4 23 | — | $191.1M |
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | $0 |
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | $458.2M |
| Q2 25 | $1.9M | — | ||
| Q2 24 | $2.2M | — | ||
| Q4 23 | — | $694.0M |
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-40.8M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | $-40.8M |
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
